Pegylated filgrastim - Bio-Ker

Drug Profile

Pegylated filgrastim - Bio-Ker

Alternative Names: BK0026

Latest Information Update: 16 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bio-Ker
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
  • Mechanism of Action Granulocyte colony stimulating factor stimulants; Nerve growth factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Neutropenia

Most Recent Events

  • 08 Aug 2013 Biomarkers information updated
  • 07 Oct 2011 Pegylated filgrastim - Bio-Ker is available for licensing as of 07 Oct 2011. http://www.multimedica.it
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top